Literature DB >> 24306343

Prenatal genetic testing with chromosomal microarray analysis identifies major risk variants for schizophrenia and other later-onset disorders.

Gregory Costain, Donna M McDonald-McGinn, Anne S Bassett.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24306343      PMCID： PMC4516409          DOI： 10.1176/appi.ajp.2013.13070880

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  9 in total

1.  Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome.

Authors:  Wai Lun Alan Fung; Rebecca McEvilly; Jessica Fong; Candice Silversides; Eva Chow; Anne Bassett
Journal:  Am J Psychiatry       Date:  2010-08       Impact factor: 18.112

Review 2.  Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease.

Authors:  Anne S Bassett; Stephen W Scherer; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

3.  Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays.

Authors:  Gregory Costain; Anath C Lionel; Daniele Merico; Pamela Forsythe; Kathryn Russell; Chelsea Lowther; Tracy Yuen; Janice Husted; Dimitri J Stavropoulos; Marsha Speevak; Eva W C Chow; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Hum Mol Genet       Date:  2013-06-27       Impact factor: 6.150

Review 4.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

Review 5.  The clinical context of copy number variation in the human genome.

Authors:  Charles Lee; Stephen W Scherer
Journal:  Expert Rev Mol Med       Date:  2010-03-09       Impact factor: 5.600

6.  Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.

Authors:  Randal G Ross; Sharon K Hunter; Lizbeth McCarthy; Julie Beuler; Amanda K Hutchison; Brandie D Wagner; Sherry Leonard; Karen E Stevens; Robert Freedman
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

7.  Chromosomal microarray versus karyotyping for prenatal diagnosis.

Authors:  Ronald J Wapner; Christa Lese Martin; Brynn Levy; Blake C Ballif; Christine M Eng; Julia M Zachary; Melissa Savage; Lawrence D Platt; Daniel Saltzman; William A Grobman; Susan Klugman; Thomas Scholl; Joe Leigh Simpson; Kimberly McCall; Vimla S Aggarwal; Brian Bunke; Odelia Nahum; Ankita Patel; Allen N Lamb; Elizabeth A Thom; Arthur L Beaudet; David H Ledbetter; Lisa G Shaffer; Laird Jackson
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

8.  Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities.

Authors:  Francesco Fiorentino; Stefania Napoletano; Fiorina Caiazzo; Mariateresa Sessa; Sara Bono; Letizia Spizzichino; Anthony Gordon; Andrea Nuccitelli; Giuseppe Rizzo; Marina Baldi
Journal:  Eur J Hum Genet       Date:  2012-12-05       Impact factor: 4.246

9.  Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Appl Clin Genet       Date:  2012-02-20
  9 in total
  12 in total

1.  Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets.

Authors:  William Warnica; Daniele Merico; Gregory Costain; Simon E Alfred; John Wei; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Biol Psychiatry       Date:  2014-05-29       Impact factor: 13.382

2.  Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.

Authors:  Anne S Bassett; Chelsea Lowther; Daniele Merico; Gregory Costain; Eva W C Chow; Therese van Amelsvoort; Donna McDonald-McGinn; Raquel E Gur; Ann Swillen; Marianne Van den Bree; Kieran Murphy; Doron Gothelf; Carrie E Bearden; Stephan Eliez; Wendy Kates; Nicole Philip; Vandana Sashi; Linda Campbell; Jacob Vorstman; Joseph Cubells; Gabriela M Repetto; Tony Simon; Erik Boot; Tracy Heung; Rens Evers; Claudia Vingerhoets; Esther van Duin; Elaine Zackai; Elfi Vergaelen; Koen Devriendt; Joris R Vermeesch; Michael Owen; Clodagh Murphy; Elena Michaelovosky; Leila Kushan; Maude Schneider; Wanda Fremont; Tiffany Busa; Stephen Hooper; Kathryn McCabe; Sasja Duijff; Karin Isaev; Giovanna Pellecchia; John Wei; Matthew J Gazzellone; Stephen W Scherer; Beverly S Emanuel; Tingwei Guo; Bernice E Morrow; Christian R Marshall
Journal:  Am J Psychiatry       Date:  2017-07-28       Impact factor: 18.112

Review 3.  Developmental trajectories in 22q11.2 deletion.

Authors:  Ann Swillen; Donna McDonald-McGinn
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-05-18       Impact factor: 3.908

4.  Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome.

Authors:  Chrystal Chan; Gregory Costain; Lucas Ogura; Candice K Silversides; Eva W C Chow; Anne S Bassett
Journal:  J Genet Couns       Date:  2015-01-13       Impact factor: 2.537

5.  Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.

Authors:  Anne S Bassett; Gregory Costain; Christian R Marshall
Journal:  Prenat Diagn       Date:  2016-11-14       Impact factor: 3.050

Review 6.  Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology.

Authors:  Sébastien Jacquemont; Guillaume Huguet; Marieke Klein; Samuel J R A Chawner; Kirsten A Donald; Marianne B M van den Bree; Jonathan Sebat; David H Ledbetter; John N Constantino; Rachel K Earl; Donna M McDonald-McGinn; Therese van Amelsvoort; Ann Swillen; Anne H O'Donnell-Luria; David C Glahn; Laura Almasy; Evan E Eichler; Stephen W Scherer; Elise Robinson; Anne S Bassett; Christa Lese Martin; Brenda Finucane; Jacob A S Vorstman; Carrie E Bearden; Raquel E Gur
Journal:  Am J Psychiatry       Date:  2022-03       Impact factor: 19.242

7.  Prenatal genetic counselling for psychiatric disorders.

Authors:  Angela Inglis; Emily Morris; Jehannine Austin
Journal:  Prenat Diagn       Date:  2016-08-23       Impact factor: 3.050

Review 8.  Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature.

Authors:  Chelsea Lowther; Gregory Costain; Dimitri J Stavropoulos; Rebecca Melvin; Candice K Silversides; Danielle M Andrade; Joyce So; Hanna Faghfoury; Anath C Lionel; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Genet Med       Date:  2014-07-31       Impact factor: 8.822

Review 9.  Practical guidelines for managing adults with 22q11.2 deletion syndrome.

Authors:  Wai Lun Alan Fung; Nancy J Butcher; Gregory Costain; Danielle M Andrade; Erik Boot; Eva W C Chow; Brian Chung; Cheryl Cytrynbaum; Hanna Faghfoury; Leona Fishman; Sixto García-Miñaúr; Susan George; Anthony E Lang; Gabriela Repetto; Andrea Shugar; Candice Silversides; Ann Swillen; Therese van Amelsvoort; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

10.  Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome.

Authors:  Lily Van; Nancy J Butcher; Gregory Costain; Lucas Ogura; Eva W C Chow; Anne S Bassett
Journal:  Genet Med       Date:  2015-06-18       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.